tm
Seeing Is Believing
tm
Seeing Is Believing
CRMD is currently covered by 5 analysts with an average price target of $14.16. This is a potential upside of $8.75 (161.74%) from yesterday's end of day stock price of $5.41.
CorMedix's activity chart (see below) currently has 23 price targets and 34 ratings on display. The stock rating distribution of CRMD is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 11.9% with an average time for these price targets to be met of 157.57 days.
Highest price target for CRMD is $19, Lowest price target is $9, average price target is $14.16.
Most recent stock forecast was given by GREGORY RENZA from RBC on 13-Mar-2024. First documented stock forecast 12-Dec-2018.
Currently out of the existing stock ratings of CRMD, 17 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
9
$4.24 (89.08%)
10
1 months 7 days ago
0/3 (0%)
$5.1 (130.77%)
Buy
5 months 4 days ago
0/1 (0%)
$8.28 (70.65%)
Buy
10
$5.24 (110.08%)
12
5 months 5 days ago
0/9 (0%)
$6.67 (200.30%)
Buy
19
$14.24 (299.16%)
16
11 months 1 days ago
0/9 (0%)
$13.9 (272.55%)
Buy
12
$7.24 (152.10%)
1 years 8 months 11 days ago
0/2 (0%)
$8.8 (275.00%)
What is CRMD (CorMedix) average time for price targets to be met?
Which analyst has the current highest performing score on CRMD (CorMedix) with a proven track record?
Which analyst has the current lower performing score on CRMD (CorMedix) with a proven track record?
Which analyst has the most public recommendations on CRMD (CorMedix)?
Which analyst is the currently most bullish on CRMD (CorMedix)?
Which analyst is the currently most reserved on CRMD (CorMedix)?
